Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

Steady state assessment [Regulatives / Guidelines]

posted by Nirali – India, 2008-12-19 08:59 (6387 d 06:29 ago) – Posting: # 2949
Views: 7,229

Dear HS,

Thanks for that valuable inputs :-)

However as per Canadian guideline, they have recommended RMANOVA with Day and Day*Treatment effects to be considered. Here, I am prefereing to do a ONE WAY ANOVA (as I am considering last three pre-dose).

Will this approach fulfill the regulatory requirement, as the study is for Europe territory?

Thanks & Regards,
NIRALI

Complete thread:

Cpd analysis in Steady state study Nirali 2008-12-18 07:29 [Regulatives / Guidelines]
- Steady state assessment Helmut 2008-12-18 15:23
  - Steady state assessmentNirali 2008-12-19 07:59
    - Steady state assessment Helmut 2008-12-19 15:00
  - Steady state assessment kram 2010-02-15 15:16

Admin contact
23,654 posts in 4,992 threads, 1,570 registered users;
127 visitors (0 registered, 127 guests [including 21 identified bots]).
Forum time: 16:28 CEST (Europe/Vienna)

The idea is to try and give all the information to help others
to judge the value of your contribution;
not just the information that leads to judgment
in one particular direction or another. Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz